Comparative Study of Regional Nerve Blocks in Primary Cleft Palate Repair
This study will evaluate whether adding a suprazygomatic maxillary nerve block to the standard palatal nerve block improves pain control after cleft palate repair surgery in children. Participants will be randomly assigned to receive either the standard palatal block alone or the standard palatal block combined with a suprazygomatic maxillary nerve block. Both techniques use medications commonly used for pain management during surgery.
The purpose of this study is to determine whether the addition of the suprazygomatic maxillary nerve block reduces postoperative pain, decreases the need for opioid medications, and improves recovery after cleft palate repair. Researchers will compare pain scores, medication use, recovery outcomes, and any treatment-related complications between the two groups.
Information collected from this study may help identify the most effective regional anesthesia approach for children undergoing cleft palate repair and may improve postoperative pain management and patient recovery.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Logan Stratton
- 電話番号:443-922-6012
- メール:lstratton@childrensnational.org
研究連絡先のバックアップ
- 名前:Albert Oh
- 電話番号:202-713-8856
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Children undergoing primary cleft palate repair or secondary velopharyngeal insufficiency (VPI) surgery.
- Eligible to receive regional anesthetic nerve blocks as part of the planned surgical procedure.
- Parent or legal guardian able and willing to provide informed consent.
- Participant meets all institutional and surgical criteria for undergoing the planned procedure.
Exclusion Criteria:
- Known allergy, hypersensitivity, or contraindication to the study anesthetic medications.
- Medical conditions that contraindicate regional anesthetic nerve block procedures.
- Coagulopathy or bleeding disorder that would increase the risk of nerve block placement.
- Active infection at or near the planned injection site.
- Inability of parent or legal guardian to provide informed consent.
- Any condition that, in the opinion of the investigator, would make participation unsafe or interfere with study assessments.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Standard Palatal Nerve Block
Participants receive the standard palatal nerve block performed during cleft palate surgery. |
Regional anesthetic block of the palate performed during cleft palate or velopharyngeal insufficiency surgery using local anesthetic. This procedure serves as the standard pain management approach and is intended to provide perioperative analgesia and reduce postoperative pain. |
|
実験的:Standard Palatal Nerve Block Plus Suprazygomatic Maxillary Nerve Block
Participants receive the standard palatal nerve block plus a suprazygomatic maxillary nerve block during cleft palate surgery. |
Regional anesthetic block of the maxillary nerve performed via a suprazygomatic approach using local anesthetic in addition to the standard palatal nerve block. The procedure is intended to enhance perioperative analgesia, decrease postoperative pain, and reduce postoperative opioid requirements following cleft palate or velopharyngeal insufficiency surgery. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Postoperative Pain Scores Measured by the Face, Legs, Activity, Cry, Consolability (FLACC) Scale
時間枠:Within the first 24 hours following surgery
|
Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale following cleft palate repair or velopharyngeal insufficiency surgery. The FLACC scale rates five behavioral categories (Face, Legs, Activity, Cry, and Consolability) from 0 to 2 each, for a total score ranging from a minimum of 0 to a maximum of 10. Higher scores indicate more pain and therefore a worse outcome. Pain scores will be compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block to evaluate the effectiveness of the additional regional anesthesia technique. |
Within the first 24 hours following surgery
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Postoperative Opioid Consumption
時間枠:Within the first 24 hours following surgery
|
Total postoperative opioid medication use will be recorded and compared between participants receiving a standard palatal nerve block and those receiving a standard palatal nerve block plus a suprazygomatic maxillary nerve block. This outcome will assess whether the additional regional anesthesia technique reduces the need for opioid analgesics following surgery. |
Within the first 24 hours following surgery
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- STUDY00001302
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared with researchers outside of the study team. Data collected for this study contain protected health information and were obtained under informed consent and institutional review board requirements that do not include plans for external sharing of individual participant-level data.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。